SCHEMBL209199

SCHEMBL209199

CC(C)(C)OC(=O)N1CCN(C(=O)c2ccc(-c3cc(Cl)c(C[C@@H]4CCN(C5CCC(O[Si](C)(C)C(C)(C)C)CC5)C4=O)c(Cl)c3)cc2)CC1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC4 P56524 1/20 0.41
MEN1 O00255 2/20 0.41
KMT2A Q03164 2/20 0.41
GPR119 Q8TDV5 9/20 0.36
CRBN Q96SW2 1/20 0.36
TP53 P04637 1/20 0.35
ALDH1A1 P00352 1/20 0.35
CYP1A2 P05177 1/20 0.35
CYP2C19 P33261 1/20 0.35
ABL1 P00519 1/20 0.35
RIN1 Q13671 1/20 0.35
NPBWR1 P48145 1/20 0.35
MCHR1 Q99705 1/20 0.35
CACNB4 O00305 1/20 0.34
CACNA1A O00555 1/20 0.34
CACNA1G O43497 1/20 0.34
CACNG3 O60359 1/20 0.34
CACNA1F O60840 1/20 0.34
CACNA1H O95180 1/20 0.34
CACNB3 P54284 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL209200 1.00 HDAC4 (0.41) HDAC4MEN1KMT2AGPR119CRBN
SCHEMBL209532 0.91 HRH1 (0.33) MEN1KMT2AALDH1A1CYP1A2CYP2C19
SCHEMBL211810 0.91 HRH1 (0.33) MEN1KMT2AALDH1A1CYP1A2CYP2C19
SCHEMBL209534 0.91 HRH1 (0.33) MEN1KMT2AALDH1A1CYP1A2CYP2C19
SCHEMBL209533 0.91 HRH1 (0.33) MEN1KMT2AALDH1A1CYP1A2CYP2C19
SCHEMBL208995 0.90 MET (0.40)
SCHEMBL208996 0.90 MET (0.40)
SCHEMBL210980 0.90 HRH3 (0.40) MEN1KMT2AALDH1A1CYP1A2CYP2C19
SCHEMBL208200 0.90 HRH3 (0.40) MEN1KMT2AALDH1A1CYP1A2CYP2C19
SCHEMBL210979 0.90 HRH3 (0.40) MEN1KMT2AALDH1A1CYP1A2CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2016047-B1 BIPHENYL AMIDE LACTAM DERIVATIVES AS INHIBITORS OF 11- BETA-HYDROXYSTEROID DEHYDROGENASE 1 LILLY CO ELI (US) 2013-08-28 EP disclosed
US-8088776-B2 Biphenyl amide lactam derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase 1 ELI LILLY AND COMPANY (US) 2012-01-03 US disclosed
US-20090156571-A1 BIPHENYL AMIDE LACTAM DERIVATIVES AS INHIBITORS OF 11-BETA-HYDROXYSTEROID DEHYDROGENASE 1 ELI LILLY AND COMPANY 2009-06-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090156571-A1 BIPHENYL AMIDE LACTAM DERIVATIVES AS INHIBITORS OF 11-BETA-HYDROXYSTEROID DEHYDROGENASE 1 HSD11B1, HSD17B1, HSD11B2 HDAC4 1077/4885MEN1 1929/4885KMT2A 1020/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.